ScoreWhy is Aarti Drugs Ltd ?
1
Poor long term growth as Operating profit has grown by an annual rate -8.96% of over the last 5 years
2
Flat results in Mar 26
- ROCE(HY) Lowest at 11.51%
- DEBTORS TURNOVER RATIO(HY) Lowest at 3.09 times
3
Consistent Underperformance against the benchmark over the last 3 years
- Along with generating -15.69% returns in the last 1 year, the stock has also underperformed BSE500 in each of the last 3 annual periods
Real-Time Research ReportHow much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is Aarti Drugs for you?
High Risk, Low Return
Absolute
Risk Adjusted
Volatility
Aarti Drugs
-15.78%
-0.46
33.96%
Sensex
-5.6%
-0.42
13.26%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
3.55%
EBIT Growth (5y)
-8.96%
EBIT to Interest (avg)
8.53
Debt to EBITDA (avg)
1.84
Net Debt to Equity (avg)
0.37
Sales to Capital Employed (avg)
1.40
Tax Ratio
7.57%
Dividend Payout Ratio
5.43%
Pledged Shares
2.47%
Institutional Holding
11.80%
ROCE (avg)
14.70%
ROE (avg)
14.40%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
17
Industry P/E
34
Price to Book Value
2.19
EV to EBIT
16.34
EV to EBITDA
12.80
EV to Capital Employed
1.87
EV to Sales
1.54
PEG Ratio
1.04
Dividend Yield
0.55%
ROCE (Latest)
11.44%
ROE (Latest)
12.58%
Loading Valuation Snapshot...
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Bearish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bullish
Bearish
Moving Averages
Bearish (Daily)
KST
Mildly Bullish
Bearish
Dow Theory
Mildly Bearish
No Trend
OBV
Mildly Bearish
No Trend
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend8What is working for the Company
OPERATING PROFIT TO INTEREST(Q)
Highest at 11.74 times
DEBT-EQUITY RATIO(HY)
Lowest at 0.37 times
NET SALES(Q)
Highest at Rs 720.30 cr
PBDIT(Q)
Highest at Rs 95.80 cr.
PBT LESS OI(Q)
Highest at Rs 69.60 cr.
-4What is not working for the Company
ROCE(HY)
Lowest at 11.51%
DEBTORS TURNOVER RATIO(HY)
Lowest at 3.09 times
Loading Valuation Snapshot...
Here's what is working for Aarti Drugs
Operating Profit to Interest - Quarterly
Highest at 11.74 times
in the last five quartersMOJO Watch
The company's ability to manage interest payments is improving
Operating Profit to Interest
Net Sales - Quarterly
Highest at Rs 720.30 cr
in the last five quartersMOJO Watch
Near term sales trend is positive
Net Sales (Rs Cr)
Operating Profit (PBDIT) - Quarterly
Highest at Rs 95.80 cr.
in the last five quartersMOJO Watch
Near term Operating Profit trend is positive
Operating Profit (Rs Cr)
Profit Before Tax less Other Income (PBT) - Quarterly
Highest at Rs 69.60 cr.
in the last five quartersMOJO Watch
Near term PBT trend is positive
PBT less Other Income (Rs Cr)
Profit Before Tax less Other Income (PBT) - Quarterly
At Rs 69.60 cr has Grown at 33.7% (vs previous 4Q average)
over average PBT of the previous four quarters of Rs 52.05 CrMOJO Watch
Near term PBT trend is positive
PBT less Other Income (Rs Cr)
Debt-Equity Ratio - Half Yearly
Lowest at 0.37 times
in the last five half yearly periodsMOJO Watch
The company has been reducing its borrowing as compared to equity capital
Debt-Equity Ratio
Here's what is not working for Aarti Drugs
Debtors Turnover Ratio- Half Yearly
Lowest at 3.09 times
in the last five half yearly periodsMOJO Watch
Company's pace of settling its Debtors has slowed
Debtors Turnover Ratio
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
